Grannus Therapeutics, Inc.
Biotechnology company · Indianapolis, Indiana, United States
Grannus Therapeutics, Inc. is a biotechnology company headquartered in Indianapolis, Indiana, United States. Its earliest recorded incorporation is in 2020. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $579,757 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $800,000 sold in a notice filed in 2024.
Grannus Therapeutics at a glance
What does Grannus Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $579,757 in total (2020 to 2021). NIH funding came from the National Cancer Institute, National Eye Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $800,000 sold (2024).
Frequently asked questions about Grannus Therapeutics
Where is Grannus Therapeutics headquartered?
Grannus Therapeutics, Inc. is headquartered in Indianapolis, Indiana, United States.
What does Grannus Therapeutics do?
Grannus Therapeutics, Inc. is a biotechnology company.
When was Grannus Therapeutics founded?
The earliest incorporation on record for Grannus Therapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- Scioto Biosciences, Inc.Indianapolis, Indiana, United States
- PharmacoPhotonics, Inc.Indianapolis, Indiana, United States
- Kovina Therapeutics Inc.Indianapolis, Indiana, United States
- Adipo Therapeutics, LLCIndianapolis, Indiana, United States
- NERx Biosciences, Inc.Indianapolis, Indiana, United States
- PinkDx, Inc.Indianapolis, Indiana, United States
- Animated Dynamics, Inc.Indianapolis, Indiana, United States
- Monon Bioventures LLCIndianapolis, Indiana, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences